Table 1.
Compounds | D10 IC50 (µM) | W2 IC50 (µM) | HMEC-1 IC50 (µM) c | SI d | SI e | ||
---|---|---|---|---|---|---|---|
D10 | W2 | D10 | W2 | ||||
22 | 0.60 ± 0.21 | 0.70 ± 0.22 | 17.6 ± 1.4 | 29.3 | 25.2 | 147.7 | 126.5 |
24 | 1.63 ± 0.35 | 1.90 ± 1.05 | 8.51 ± 0.76 | 5.2 | 4.5 | 48.5 | 41.6 |
25 | 5.06 ± 1.68 | 5.02 ± 1.81 | 20.4 ± 1.60 | 4.0 | 4.1 | 11.0 | 11.1 |
26 | 1.21 ± 0.20 | 1.22 ± 0.24 | 17.9 ± 1.10 | 14.8 | 14.7 | – f | – f |
27 | 1.12 ± 0.40 | 0.81 ± 0.19 | 3.59 ± 0.72 | 3.2 | 4.4 | 32.6 | 45.0 |
a CQ as positive control: D10 IC50 (μM) = 0.04 ± 0.01; W2 IC50 (μM) = 0.54 ± 0.28; not cytotoxic. b Data are the mean ± SD of three different experiments in duplicate. c Camptothecin as positive control: IC50 (μM) = 0.018 ± 0.008. d SI = IC50 HMEC-1/IC50 P. falciparum strain. e SI = IC50 NIH-3T3/IC50 P. falciparum strain; cytotoxicity values on NIH-3T3 (µM) of compounds 22 and 24–27 are reported in a previous work [8]. f SI was not calculated since 26 is not active on NIH-3T3.